Vivos (RDGL) Total Current Liabilities (2010 - 2025)
Vivos' (RDGL) quarterly Total Current Liabilities came in at $117892.0 in Q4 2025, up 36.75% year-on-year from $86209.0 in Q4 2024, and up 4.61% quarter-over-quarter from $112693.0 in Q3 2025.
Vivos (RDGL) Total Current Liabilities (2010 - 2025) Analysis & Trends
Vivos has disclosed Total Current Liabilities across 16 years of filings, most recently posting $117892.0 for Q4 2025.
- Total Current Liabilities for Q4 2025 came in at $117892.0, up 36.75% year-over-year; the trailing twelve-month figure through Dec 2025 was $117892.0 (up 36.75% YoY), and the FY2025 annual result was $117892.0, up 36.75% from the prior year.
- Total Current Liabilities came in at $117892.0 for Q4 2025 at Vivos, up from $112693.0 in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $687297.0 in Q1 2021 to a low of $48820.0 in Q3 2024.
- The 5-year median for Total Current Liabilities is $114094.0 (2023), against an average of $197851.8.
- Across the five-year window, Total Current Liabilities slumped 87.56% in 2022 and surged 199.91% in 2023, its largest moves.
- Vivos' Total Current Liabilities stood at $166915.0 in 2021, then tumbled by 51.06% to $81692.0 in 2022, then soared by 199.91% to $245004.0 in 2023, then slumped by 64.81% to $86209.0 in 2024, then soared by 36.75% to $117892.0 in 2025.
- The last three Total Current Liabilities figures came in at $117892.0 (Q4 2025), $112693.0 (Q3 2025), and $96458.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 9.50 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.70 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.22 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 1.15 Bn |
| 10 | Vivos | - | - | -3,105.00 | 117,892.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 117,892.00 |
| Sep 30, 2025 | 112,693.00 |
| Jun 30, 2025 | 96,458.00 |
| Mar 31, 2025 | 115,378.00 |
| Dec 31, 2024 | 86,209.00 |
| Sep 30, 2024 | 48,820.00 |
| Jun 30, 2024 | 166,560.00 |
| Mar 31, 2024 | 74,766.00 |
| Dec 31, 2023 | 245,004.00 |
| Sep 30, 2023 | 107,369.00 |
| Jun 30, 2023 | 112,810.00 |
| Mar 31, 2023 | 48,989.00 |
| Dec 31, 2022 | 81,692.00 |
| Sep 30, 2022 | 160,953.00 |
| Jun 30, 2022 | 215,093.00 |
| Mar 31, 2022 | 85,515.00 |
| Dec 31, 2021 | 166,915.00 |
| Sep 30, 2021 | 619,392.00 |
| Jun 30, 2021 | 607,231.00 |
| Mar 31, 2021 | 687,297.00 |